Navigation Links
PM's science prize for Ian Frazer
Date:10/17/2008

UQ's cervical cancer vaccine co-creator Professor Ian Frazer has won the 2008 Prime Minister's Prize for Science.

Professor Frazer, Director of UQ's Diamantina Institute for Cancer, Immunology and Metabolic Medicine, was presented with his prize by Prime Minister Kevin Rudd at a special ceremony in the Great Hall, Parliament House Canberra tonight (Thursday, October 16) .

The Prime Minister's Prize for Science is the nation's pre-eminent award for excellence in science and acknowledges the contributions of Australian scientists to economic and social wellbeing in Australia and the world.

Awarded for an outstanding specific achievement in any area of science advancing human welfare or benefiting society, it can encompass the physical, chemical, biological and technological sciences, mathematics and/or engineering.

The Prime Minister's Prize for Science comprises a grant of $300,000. The winner also serves on the Prime Minister's Science, Engineering and Innovation Council for a year.

Professor Frazer said he would donate his prize money to the University for a research program to develop further vaccines.

Last month, Professor Frazer, 2006 Australian of the Year and inaugural winner of the Queensland Smart State Premier's Fellowship in 2006, was announced as the winner of the Balzan Prize for International Medicine.

Together with his late research partner Dr Jian Zhou, Professor Frazer contributed to the development of a vaccine for cervical cancer.

"I'm honoured to be chosen as the 2008 recipient of the Prime Minister's Prize for Science, and delighted at the recognition of the contribution of science to the community that this prize makes," Professor Frazer said.

"I will use the opportunity granted by my selection to further the promotion of science as the best approach to solving the many challenges we face in society, in areas as diverse as health and the environment."

Since the vaccine's global application in 2006, more than 40 million doses have been administered to women and girls in more than 90 countries.

Acting UQ Vice-Chancellor Professor Michael Keniger congratulated Professor Frazer and said the Prime Minister had made an excellent choice

"As well as being a brilliant scientist whose work has a global impact, Professor Frazer has an infectious enthusiasm for the benefits of research and never tires in spreading the word to Australians and people all over the world," Professor Keniger said.

The vaccine protects against about 70 percent of human papillomavirus-related cervical cancers, with more than 270,000 women previously dying each year from the disease.

UQ now has two Prime Minister's Prize for Science recipients the other being Professor Mandyam Srinivasan, who won the award in 2006, just prior to his appointment to UQ as Head of Visual Neuroscience within the Queensland Brain Institute.


'/>"/>

Contact: Shirley Glaister
communications@uq.edu.au
61-733-651-931
Research Australia
Source:Eurekalert

Related medicine news :

1. Video: The Science Behind the Soak - a Coping Tool for Todays Changing World
2. Albany College of Pharmacy and Health Sciences - New Name, Same Commitment to the Advancement of Health Care
3. Breaking News: Finally! A Catholic Bishop Confirms that a Catholic Cannot Vote for Obama in Good Conscience
4. Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs
5. NuView Life Sciences Inc. Assumes Management of Trace Life Sciences Inc. Radioisotope Production Facility
6. Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging
7. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimers Patents and Patent Applications
8. Managing Gas Isn't Rocket Science
9. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
10. Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
11. Gene Network Sciences Announces Drug Development Collaboration with Biogen Idec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... City ... holidays (IBT World Travel Trends Report). As travelers visit both urban destinations, they ... temperatures, and prolonged sun exposure. In response, the outdoor industry has blurred the ...
(Date:3/28/2017)... ... , ... Alert Sentry Group LLC., a leader in the Personal Emergency Response ... and the iSAFE Plus. These iSAFE products are the most affordable and most advanced ... iSAFE Plus offer direct GPS Location and two-way calling with the push of a ...
(Date:3/28/2017)... ... 2017 , ... The Radiology Business Management Association (RBMA) is pleased ... new executive director. Mr. Still was selected through a careful months-long search by the ... is known to our members, has been a part of building the RBMA since ...
(Date:3/28/2017)... Vilnius, Lithuania (PRWEB) , ... March 28, 2017 ... ... identification technologies, today announced the release of two biometric time and attendance tracking ... Bio Attendance 4.0 software. NCheck Cloud Bio Attendance uses biometric face recognition ...
(Date:3/28/2017)... ... 28, 2017 , ... The Executives, Staff & Clients of MGE: Management Experts ... for Tots Literacy Campaign at their Semi-Annual Graduation and Fundraiser Event at MGE’s St. ... ranks at number 14 internationally in literacy. Statistically, a direct relation can be a ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TORONTO , March 28, 2017 /PRNewswire/ ... full service medical device development firm, announced today that ... Toronto -based medical device industrial design and ... medtech companies throughout North America ... medical device talent spanning the design, engineering, regulatory, and ...
(Date:3/28/2017)... , March 28, 2017 Emosis SAS, ... new business entity, Emosis Ltd, headquartered in Tel Aviv ... novel assays complementing the mother company existing technology platform and test ... sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. Emosis ...
(Date:3/28/2017)... 2017 RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... Patent Office (JPO) for the composition of matter ... for the treatment or prevention of fibrotic disorders, ... proliferative retinopathy (Japanese Patent #: 6060071).  This patent ...
Breaking Medicine Technology: